Femovate by Guidea’s Post

Nice to see Rachel Bartholomew of Hyivy Health in this article by The Guardian about the disadvantages the women behind femtech are facing including: - a misconception that the market is too niche (it isn't, women are 51% of the population with control of 80% of the healthcare spend) - censorship, not being able to use the medical terms for for women's bodies and conditions (double standard since it is fine to use the words for men's bodies) stymying marketing and education efforts - funding, the UK and US government are now starting to fill in the gaps left by the lack of VC funding, but we need additional sources of funding https://lnkd.in/e3QuQPQb #womenshealthequity #healthinnovation #femtech

The ‘huge disadvantage’ women behind femtech phenomenon face

The ‘huge disadvantage’ women behind femtech phenomenon face

theguardian.com

To view or add a comment, sign in

Explore topics